Navigation Links
Arbios Commences Process to Seek European Marketing Approval for SEPET(TM)
Date:4/15/2008

WALTHAM, Mass., April 15 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (OTC Bulletin Board: ABOS) today announced that it has commenced the marketing authorization process in the European Union to pursue CE Marking the SEPET(TM) Liver Assist Device. The Company has engaged the British Standards Institute (BSI), one of the leading notified bodies in Europe, to assist the Company in its effort to obtain a CE Mark for SEPET, which is a sterile, disposable cartridge with proprietary membrane permeability characteristics for use in treating patients with chronic liver failure. CE Marking indicates that the product complies with the essential requirements of the relevant European health, safety and environmental protection legislation and allows sale of the product within the European Union (28 countries) and the European Free Trade Association (3 countries).

"We are pleased to announce this arrangement with BSI, and look forward to advancing our market approval and product acceptance strategy for SEPET in Europe," commented Shawn Cain, President and Chief Executive Officer of Arbios. "Importantly, based on guidance from BSI, we will seek approval of SEPET using data from our recently completed feasibility trial. If no additional clinical data are necessary, and if we meet all the requirements for CE Marking, we believe that our CE Mark filing for SEPET will be completed by the beginning of 2009. We are also seeking a European distribution, marketing, and sales partner to assist us in introducing SEPET into the European market," Mr. Cain added.

About Arbios' SEPET(TM) Liver Assist Device

The SEPET(TM) Liver Assist Device is a sterile, disposable cartridge containing microporous hollow fibers with proprietary permeability characteristics. When a patient's blood is passed through these fibers, blood plasma components of specific molecular weights are expressed through the micropores, thereby cleansing the blood of harmful impurities (e.g., hepat
'/>"/>

SOURCE Arbios Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
2. Clal Industries Commences Additional Offer Period for Fundtech Tender Offer
3. China Biologic Products Commences Trading on OTC Bulletin Board
4. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
5. NPS Pharmaceuticals Commences Tender Offer for 3.0% Convertible Notes Due 2008
6. Raven biotechnologies and Bioprocessing Technology Institute Announce Collaboration to Advance Discovery of Stem Cell Antibodies
7. Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
8. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
9. Phlo Reverse Stock Split Process Completed; Trading Symbol Changed to PHCP
10. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
11. Plurality Completes R&D of its HAL-256 Multicore Processor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 - Elsevier, a world-leading provider of scientific, technical ... publication of a recent study in Reproductive ... showing that those with an abnormal chromosomal composition can ... developed to blastocysts, thereby classifying the risk of genetic ... same group has undertaken a retrospective study, using their ...
(Date:5/17/2013)... 2013 •    First of its kind research ... ,     New facility will help solve crop stresses ... Syngenta unveiled its new crop research facility during ... Innovation Center. The first of its kind, $72 million ... agricultural climate and precisely measure plant inputs – the ...
(Date:5/17/2013)... 17, 2013  Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
(Date:5/17/2013)... 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased to ... Switzerland -based Kenta Biotech to ... antibody (mAb) products, and technologies. This asset portfolio ... treatment of infections by common pathogens including drug ... Pseudomonas aeruginosa , Acinetobacter baumannii ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... Bolder BioTechnology, Inc. today announced that it has ... Innovation Research (SBIR) grant from the National Institute of ... of Health (NIH). The grant will be used ... the company,s proprietary long-acting growth hormone product, which is ...
... Offers Healthcare Workers Consistent Cleaning , ... IRVINE, Calif., Dec. 16 Advanced ... availability of the EVOTECH(TM) Endoscope Cleaner and Reprocessor, ... manual cleaning of endoscopes. The results of the ...
... Leadership, Vision and Experience to Company , ... Dec. 16 Xceleron, the global leader in predictive ... today Michael Butler, Ph.D., has been named President and ... Butler brings to Xceleron a balance of sales, operations ...
Cached Biology Technology:Bolder BioTechnology Receives $1.9 Million NIH Grant to Continue Development of Long-Acting Growth Hormone Product 2ASP Announces Availability of EVOTECH(TM) Endoscope Cleaner and Reprocessor - First Commercially Available System to Eliminate Manual Cleaning of Endoscopes 2Xceleron Names Michael Butler as President & CEO 2
(Date:5/16/2013)... creature with ,scissor hand-like, claws in fossil records and ... star. , The 505 million year old fossil ... is a distant ancestor of lobsters and scorpions, was ... role as Edward Scissorhands - a movie about an ... scissors for hands. , Kooteninchela deppi ...
(Date:5/16/2013)... can trigger hematopoiesis at sites outside the bone marrow ... of Ludwig-Maximilians-Universitaet (LMU) in Munich now show that a ... formation of blood cells. , Balanced hematopoiesis is essential ... development, hematopoiesis takes place mainly in the liver and ... bone marrow, and this tissue normally serves as the ...
(Date:5/16/2013)... Top neuroscientists from Canada and around the world ... Annual Canadian Neuroscience Meeting will showcase the latest ... system and reveal clues to understanding the disorders ... neuroscience research, and this meeting will showcase the ... the world," says Sam David, President of the ...
Breaking Biology News(10 mins):Actor Johnny Depp immortalized in ancient fossil find 2Herpes infections: Natural killer cells activate hematopoiesis 27th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2
... was responsible for about two-thirds of toxic lead that ... latter two-thirds of the 20th century, according to a ... . Researchers from Case Western Reserve University say ... cities across the U.S. and reinforces concerns about the ...
... blood sugar levels may also influence a person,s sensitivity to ... the University of Maryland School of Medicine. They found that ... as glucagon decreases the taste system,s sensitivity to sweetness. That ... how foods taste, according to the study published online June ...
... New York, NY, June 15 Robert H. Wurtz, ... is the recipient of the 2010 Neuroscience Prize of The ... brain processes visual information and controls eye movements laid the ... This research has led scientists to a deeper understanding of ...
Cached Biology News:Leaded gasoline predominant source of lead exposure in latter 20th century 2Leaded gasoline predominant source of lead exposure in latter 20th century 3UM School of Medicine scientists find hormone influences sensitivity to sweetness 2Neuroscientist Robert H. Wurtz receives the $500,000 Gruber neuroscience prize 2Neuroscientist Robert H. Wurtz receives the $500,000 Gruber neuroscience prize 3
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
... the ability to quickly and accurately copy or ... perfect candidate for inclusion in these high speed ... with all the Cartesian products to allow integration ... to copy plates in seconds or reformat low ...
This modular benchtop fume hood ventilates and purifies chemical fumes, allowing safe indoor release of exhaust. Bonded charcoal filters remove most organic contaminants. Options include final HEPA f...
... siRNA Tracker Intracellular Localization Kit with ... forward approach to directly label and ... an efficient yet non-destructive manner, for ... and functional inhibition of target gene ...
Biology Products: